Different comparison of mean SR. homocystene in serum 25 – hydroxyvitamin D in acute stroke

https://doi.org/10.53730/ijhs.v6nS5.10037

Authors

  • Sahu Padmini Assistant Professor, Department of Surgery, Bhima Bhoi Medical College and Hospital, Balangir
  • Sahu Y. P. Assistant Professor, Department of Pharmacology VIMSAR, Burla
  • Marndi Gujaram Associate professor, Department of Pharmacology, GMC&H, Keonjhar
  • Dhone Pravin G.* Professor & Head, Department of Pharmacology, RSDKS GMC, Ambikapur

Keywords:

serum 25, hydroxyvitamin D, homocysteine, stroke

Abstract

The active form of vitamin D is 1,25 dihydroxy vitamin D. Renal and many extra renal tissues are able to synthesize 1,25 dihydroxy vitamin D on a local and intracellular level. Local tissue level of 1,25 di-hydroxyvitamin D is determined by concentration of circulating 25(OH) vitamin D level. Stroke is a common worldwide health problem. It is a major cause of morbidity, mortality and disability in developed as well as developing countries. Both vitamin D deficiency and stroke are very common in urban and rural India. Hence this study was designed to evaluate the association of vitamin D deficiency in acute stroke. This study shows the different comparison of MEAN SR. HOMOCYSTENE in serum 25 – hydroxyvitamin D in acute stroke and found to be in total serum homocysteine levels were 19.64 micro mole/l in cases than 10.1 in control   However the difference was statistically highly significant (p<.0002).

Downloads

Download data is not yet available.

References

GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the

Global Burden of Disease Study 2013. Lancet 385: 117–71. doi:10.1016/S0140-6736(14)61682-2 . PMC 4340604

Jeyraj durai pandian, Paulin sudhan; stroke epidemiology and stroke care services in India, journal of stroke 11,137-138(2013)

Hugh S, Markus-An introduction to stroke Aho K, Harmsen P, H atano S, Smirnov VE. Cerebrovascular disease in community: results of WHO collaborative study. Bull world Health Organ 1980; 58:113-30

Sun Q, Pan A, Hu FB, Manson JE, Rexored KM-25HYDROXYVITAMIN D level and risk of stroke, A prospective study and meta-analysis, Stroke 2012:43,1470-7

Brondum jacobson P, Nordestagaard BG, Schnohr P ,25 Hydroxyvitamin D and symptomatic ischemic stroke; an original study and meta-analysis 2013;38-47

Brewer L C , Michos E D. Vitamin D in atherosclerosis and vascular disease, Current drug target 2011;12:54-60

Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006; 116:2062–72

Muscogiuri G. Vitamin D: past, present and future perspectives in the prevention of chronic diseases. Eur J Clin Nutr. 2018;72: 1221–5

Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014; 2:76–89

Grant WB. Review of recent advances in understanding the role of vitamin D in reducing cancer risk: breast, colorectal, prostate, and overall cancer. Anticancer Res. 2020; 40:491–9

Moreno LA, Valtueña J, Pérez-López F, González-Gross M. Health effects related to low vitamin D concentrations: beyond bone metabolism. Ann Nutr Metab. 2011; 59:22–7

Dirks NF, Ackermans MT, Lips P, de Jongh RT, Vervloet MG, de Jonge R, et al. The when, what & how of measuring vitamin D metabolism in clinical medicine. Nutrients 2018;10:482.

Published

30-06-2022

How to Cite

Padmini, S., Sahu, Y. P., Gujaram, M., & Dhone, P. G. (2022). Different comparison of mean SR. homocystene in serum 25 – hydroxyvitamin D in acute stroke. International Journal of Health Sciences, 6(S5), 5454–5461. https://doi.org/10.53730/ijhs.v6nS5.10037

Issue

Section

Peer Review Articles

Most read articles by the same author(s)

1 2 3 > >>